Immunic Inc (NASDAQ: IMUX) kicked off on Monday, up 9.30% from the previous trading day, before settling in for the closing price of $0.58. Over the past 52 weeks, IMUX has traded in a range of $0.51-$1.39.
Healthcare Sector giant saw their annual sales surged by 26.01% over the last five years. While this was happening, its average annual earnings per share was recorded 38.11%. With a float of $118.71 million, this company’s outstanding shares have now reached $120.28 million.
Immunic Inc (IMUX) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Immunic Inc is 1.31%, while institutional ownership is 52.21%. The most recent insider transaction that took place on Jun 13 ’25, was worth 16,694. In this transaction Executive Chairman of this company bought 20,000 shares at a rate of $0.83, taking the stock ownership to the 36,032 shares. Before that another transaction happened on Jun 05 ’25, when Company’s President and COO bought 12,512 for $0.79, making the entire transaction worth $9,884. This insider now owns 12,512 shares in total.
Immunic Inc (IMUX) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.25 earnings per share (EPS), lower than consensus estimate (set at -0.24) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.11 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 38.11% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 24.34% during the next five years compared to 26.01% growth over the previous five years of trading.
Immunic Inc (NASDAQ: IMUX) Trading Performance Indicators
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.87, a number that is poised to hit -0.09 in the next quarter and is forecasted to reach -0.33 in one year’s time.
Technical Analysis of Immunic Inc (IMUX)
Analysing the last 5-days average volume posted by the [Immunic Inc, IMUX], we can find that recorded value of 1.49 million was lower than the volume posted last year of 1.5 million. As of the previous 9 days, the stock’s Stochastic %D was 54.03%.
During the past 100 days, Immunic Inc’s (IMUX) raw stochastic average was set at 21.34%, which indicates a significant decrease from 89.30% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0420 in the past 14 days, which was lower than the 0.0549 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6804, while its 200-day Moving Average is $0.8544. Now, the first resistance to watch is $0.6536. This is followed by the second major resistance level at $0.6701. The third major resistance level sits at $0.6872. If the price goes on to break the first support level at $0.6200, it is likely to go to the next support level at $0.6029. Now, if the price goes above the second support level, the third support stands at $0.5864.
Immunic Inc (NASDAQ: IMUX) Key Stats
The company with the Market Capitalisation of 76.65 million has total of 120,285K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -100,510 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -25,580 K.
